Toda criança merece um futuro — faça uma doação via pix. DOE AGORA

|
|
|
|
|
|
|
|
|
|
|

MBI é destaque em matéria do MIT News

“The MBI blueprint for funding cures for rare diseases is replicable and likely to disrupt the standard way health care research is funded and carried out by radically shortening the timeline.” MBI has been highlighted by one of the most prestigious institutions in the world, MIT – Massachusetts Institute of Technology. An article showcasing our […]

Canal de TV Fox 5 destaca a pesquisa da MBI nos Estados Unidos

During Brain Cancer Awareness Month, Fernando Goldsztein, MBI’s founder, and Dr. Roger J. Packer, scientific leader, appeared live on FOX 5 DC to share details about our groundbreaking work. FOX 5, a regional affiliate of Fox Broadcasting Company, reaches over 200 million viewers daily across the U.S. Watch the full segment here. While awareness opens […]

Fundador da MBI fala dos avanços da ciência no podcast da Society for Neuro Oncology Latin America

A conversation about neuro-oncology—and about life. That was the focus of the latest episode of the SNOLA (Society for Neuro-Oncology Latin America) podcast, featuring MBI founder Fernando Goldsztein. Fernando joined two leading experts from SNOLA’s board: Dr. Caroline Chaul Barbosa, Neuro-oncologist at Hospital Sírio-Libanês, and Dr. Marcos Vinicius Calfat Maldaun, Neurosurgeon, Director of the Neuro-oncology […]

Fundador da MBI é destaque no podcast Líderes Extraordinários do YPO, com Ventura Alonso Pires

“Research into cures for rare diseases that haven’t been studied—it’s incredible—relies solely on philanthropy.” This was one of the striking insights shared by Fernando Goldsztein during his conversation with lawyer and host Ventura Alonso Pires on Extraordinary Leaders, the podcast from YPO Cast Brazil. YPO is a global organization that brings together top business leaders […]

Avançando na pesquisa sobre câncer pediátrico: atualizações da reunião do Cure Group 4

On January 29, 2025, MBI researchers joined the latest Cure Group 4 Consortium meeting, connecting experts from the US, Canada, and Germany. The team discussed preparations for two upcoming FDA-approved clinical trials and set new research goals. Dr. Gene Hwang, head of Oncology at Children’s National in Washington, D.C., highlighted the impact of these efforts, […]

Acelerando o progresso: financiando a esperança para o câncer cerebral infantil

Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma relapsing in 30% of cases. Current treatments, developed in the 1980s, often cause severe, lifelong side effects—when survival is even possible. Now, hope is within reach. Three groundbreaking clinical trials are ready to launch, but $3 million is needed to fund and […]